JP2013535209A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535209A5
JP2013535209A5 JP2013522265A JP2013522265A JP2013535209A5 JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5 JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5
Authority
JP
Japan
Prior art keywords
cell
seq
primer
nucleic acid
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013522265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535209A (ja
JP6192537B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/063538 external-priority patent/WO2012017081A1/en
Publication of JP2013535209A publication Critical patent/JP2013535209A/ja
Publication of JP2013535209A5 publication Critical patent/JP2013535209A5/ja
Application granted granted Critical
Publication of JP6192537B2 publication Critical patent/JP6192537B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013522265A 2010-08-06 2011-08-05 T細胞の標的抗原の同定 Expired - Fee Related JP6192537B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10008233 2010-08-06
EP10008233.8 2010-08-06
PCT/EP2011/063538 WO2012017081A1 (en) 2010-08-06 2011-08-05 Identification of t cell target antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016197135A Division JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Publications (3)

Publication Number Publication Date
JP2013535209A JP2013535209A (ja) 2013-09-12
JP2013535209A5 true JP2013535209A5 (https=) 2014-08-28
JP6192537B2 JP6192537B2 (ja) 2017-09-06

Family

ID=44023005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013522265A Expired - Fee Related JP6192537B2 (ja) 2010-08-06 2011-08-05 T細胞の標的抗原の同定
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Country Status (5)

Country Link
US (2) US9678061B2 (https=)
EP (3) EP2601521B1 (https=)
JP (2) JP6192537B2 (https=)
CA (1) CA2806440A1 (https=)
WO (1) WO2012017081A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2726702T3 (es) 2009-01-15 2019-10-08 Adaptive Biotechnologies Corp Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
AU2012309830B2 (en) * 2011-09-15 2017-03-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors recognizing HLA-A1- or HLA-Cw7-restricted mage
US9824179B2 (en) * 2011-12-09 2017-11-21 Adaptive Biotechnologies Corp. Diagnosis of lymphoid malignancies and minimal residual disease detection
ES3011307T3 (en) * 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
EP3372694A1 (en) * 2012-03-05 2018-09-12 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
HUE029357T2 (en) 2012-05-08 2017-02-28 Adaptive Biotechnologies Corp Preparations and devices for measuring and calibrating amplification distortion in multiplex PCR reactions
US20140065629A1 (en) * 2012-08-29 2014-03-06 Israel Barken Methods of treating diseases
US20140065098A1 (en) * 2012-08-29 2014-03-06 Israel Barken Method to augment immune system in response to disease or injury
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
US20140356318A1 (en) * 2013-05-28 2014-12-04 Israel Barken Adoptive cell therapy with specific regulatory lymphocytes
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US11203783B2 (en) 2013-11-21 2021-12-21 Repertoire Genesis Incorporation T cell receptor and B cell receptor repertoire analysis system, and use of same in treatment and diagnosis
WO2015143558A1 (en) 2014-03-27 2015-10-01 British Columbia Cancer Agency Branch T-cell epitope identification
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
SI3132247T1 (sl) 2014-04-16 2021-12-31 Juno Therapeutics Gmbh Postopki, kompleti in naprava za povečanje populacije celic
CA2946312A1 (en) 2014-04-23 2015-10-29 Juno Therapeutics, Inc. Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
US10526391B2 (en) 2014-07-22 2020-01-07 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA2976580A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
EP3112375A1 (en) * 2015-07-03 2017-01-04 Ludwig-Maximilians-Universität München Antigenic peptides for the diagnosis, therapy monitoring and/or treatment of psoriasis vulgaris
MX2018003534A (es) * 2015-09-25 2019-04-25 Abvitro Llc Proceso de alto rendimiento para identificacion de blanco de receptor de celula t de secuencias de receptor de celula t apareadas de manera natural.
AU2016341529B2 (en) 2015-10-22 2023-03-30 Juno Therapeutics Gmbh Methods for culturing cells and kits and apparatus for same
MX2018004875A (es) 2015-10-22 2018-08-01 Juno Therapeutics Gmbh Metodos para cultivar celulas y kits y aparatos para ello.
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
EP3368691A4 (en) * 2015-10-27 2019-04-03 Arizona Board of Regents on behalf of Arizona State University HIGH-SCREEN-TYPE IDENTIFICATION OF ANTIGENES AND EPITOPES FOR T-CELL DETECTION
EP4212547A1 (en) 2015-12-03 2023-07-19 Juno Therapeutics, Inc. Modified chimeric receptors and related compositions and methods
WO2018053374A2 (en) * 2016-09-16 2018-03-22 Memorial Sloan Kettering Cancer Center Methods and compositions for t-cell epitope screening
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
JP6803480B2 (ja) 2016-11-07 2020-12-23 ジェノヴィー エービーGenovie Ab T細胞受容体の合成及びtcr提示細胞への安定なゲノム組込みのための二部分装置
DK4039800T5 (da) 2016-11-07 2024-07-29 Genovie Ab Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener
EP3535290B1 (en) * 2016-11-07 2024-01-10 Genovie AB An engineered two-part cellular device for discovery and characterisation of t-cell receptor interaction with cognate antigen
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
WO2018213803A1 (en) * 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
CA3097396A1 (en) 2018-04-19 2019-10-24 Baylor College Of Medicine Reprogramming cd4 t cells into cytotoxic cd8 cells by forced expression of cd8ab and class 1 restricted t cell receptors
US12516099B2 (en) 2018-08-09 2026-01-06 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
TW202031888A (zh) * 2018-08-24 2020-09-01 日商組庫創世紀股份有限公司 T細胞受體及b細胞受體之功能性次單元成對基因之解析方法
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
CN114807125B (zh) * 2022-05-20 2023-09-12 纳昂达(南京)生物科技有限公司 测序文库接头、测序文库及其构建方法、提升ngs建库连接效率的方法
WO2024124132A1 (en) 2022-12-09 2024-06-13 Juno Therapeutics, Inc. Machine learning methods for predicting cell phenotype using holographic imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US20010053523A1 (en) * 1995-06-02 2001-12-20 M&E Biotech A/S. Method for identification of biologically active peptides and nucleic acids
JP2000505650A (ja) * 1996-02-08 2000-05-16 アメリカ合衆国 樹状突起細胞を形質転換し、そしてt細胞を活性化するための方法及び組成物
US6429286B1 (en) 1997-04-16 2002-08-06 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Immunoregulatory molecules for costimulatory signal transduction
US6872518B2 (en) * 1997-09-22 2005-03-29 University Of Rochester Methods for selecting polynucleotides encoding T cell epitopes
DE10009341A1 (de) * 2000-02-22 2001-09-06 Florian Kern Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
JP4812951B2 (ja) 2001-03-21 2011-11-09 一般財団法人化学及血清療法研究所 特異性不明のt細胞のクローン化法及びその認識ペプチドリガンドの同定方法
CA2445181A1 (fr) 2001-04-13 2002-10-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procede d'analyse des lymphocytes t par le biais des recepteurs des lymphocytes t d'un organisme
US20030003485A1 (en) * 2001-05-15 2003-01-02 Ludwig Institute For Cancer Research Methods for identifying antigens
AU2003217384A1 (en) 2002-02-13 2003-09-04 Ludwig Institute For Cancer Research Isolated peptides which bind to hla molecules and uses thereof
EP1976981A2 (en) 2005-11-10 2008-10-08 The University Of Chicago Hcv-reactive t cell receptors
JP5292550B2 (ja) 2007-03-23 2013-09-18 静岡県 T細胞レセプターβ鎖遺伝子及びα鎖遺伝子
GB0712670D0 (en) * 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
AU2009244634B2 (en) * 2008-04-16 2014-12-18 iRepertoire, Inc. Method for evaluating and comparing immunorepertoires
US7892202B2 (en) 2008-05-09 2011-02-22 Merit Medical Systems, Inc. System and method for inflation syringe with improved display
EP2364368B1 (en) * 2008-11-07 2014-01-15 Sequenta, Inc. Methods of monitoring conditions by sequence analysis

Similar Documents

Publication Publication Date Title
JP2013535209A5 (https=)
Liu et al. Applications of immunogenomics to cancer
Naghavian et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
JP6918703B2 (ja) がんを治療するための方法
US8313894B2 (en) Antigen screening system
JP2015528443A (ja) 新規マイナー組織適合抗原を同定するための方法
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
FI3535290T3 (fi) Keinotekoinen kaksiosainen solulaite T-solun reseptorin vuorovaikutuksen havaitsemiseksi ja luonnehtimiseksi kognaattiantigeenin kanssa
Vigdorovich et al. Repertoire comparison of the B‐cell receptor‐encoding loci in humans and rhesus macaques by next‐generation sequencing
WO2019231856A1 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
JP2013521789A5 (https=)
AU2022232196A1 (en) Transmembrane neoantigenic peptides
Rieder et al. Experimental tools to identify RNA-protein interactions in Helicobacter pylori
JP2012516686A5 (https=)
US20240110311A1 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
Schwarz et al. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells
JP2014521316A5 (https=)
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
JP2018525034A5 (https=)
Quiniou et al. Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens
Champagne et al. Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
JP2021502110A5 (https=)
WO2025097243A1 (en) Colorectal tumor antigens and uses thereof
Bousbaine et al. Antigen-specific induction of CD4+ CD8αα+ intraepithelial T lymphocytes by Bacteroidetes species
Ghahremani et al. Molecular analysis of infectious bronchitis viruses isolated in Iran from 1998-2008